Regen BioPharma, Inc.

RGBP · OTC
Analyze with AI
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Activities
Net Income-$1$1$2-$7
Dep. & Amort.$0$0$0$0
Deferred Tax$0-$0-$0-$0
Stock-Based Comp.$0$0$0$0
Change in WC$0-$2-$3$4
Other Non-Cash$0$1$0$1
Operating Cash Flow-$1-$0-$1-$1
Investing Activities
PP&E Inv.$0-$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0-$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$0$0$1
Financing Cash Flow$1$0-$0$1
Forex Effect$0$0$0$0
Net Chg. in Cash-$0$0-$1$1
Supplemental Information
Beg. Cash$0$0$1$0
End Cash$0$0$0$1
Free Cash Flow-$1-$0-$1-$1